5 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
28 Jul 23
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
5:20pm
, product quality or supply issues, or a cure for HIV is found; unforeseen expenses that the Company must incur. We refer current and potential investors
40-F
2019 FY
EX-99.11
THTX
Theratechnologies Inc.
25 Feb 20
Annual report (Canada)
8:11am
to the Product; (ii) a complaint relating to the Product quality; or (iii) any report of any other problem involving Client’s product (e.g
40FR12B
EX-99.57
THTX
Theratechnologies Inc.
27 Sep 19
Initial registration of securities (Canada)
5:05pm
into a Manufacturing Agreement with WuXi Apptec, prior to the full BLA submission to the FDA, for the manufacturing of the First Formulation of the Product … .
Quality Requirements. All Product supplied by TaiMed will be tested, manufactured and released in accordance with all applicable quality standards
40-F
2011 FY
EX-99.88
THTX
Theratechnologies Inc.
13 Jun 11
Annual report (Canada)
12:00am
. For purposes of this Agreement, a “recall” shall include any market withdrawal, communication (informing the end-user of a real or potential Product … quality, safety or performance issue) or instructions issued by BD or Buyer to an end-user that provides instructions regarding handling and storage
40FR12B
EX-99.88
THTX
Theratechnologies Inc.
13 Jun 11
Initial registration of securities (Canada)
12:00am
-user of a real or potential Product quality, safety or performance issue) or instructions issued by BD or Buyer to an end-user that provides
- Prev
- 1
- Next